Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2002-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.87.8.8710PMID 12161475
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.

  2001cited by this paper
• Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.

  2001cited by this paper
• Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception.

  2001cited by this paper
• Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.

  2000cited by this paper
• Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo‐controlled feasability study for male contraception

  2000cited by this paper
• Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.

  2000cited by this paper
• Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men.

  2000cited by this paper
• Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.

  1999cited by this paper
• A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.

  1999influential reference
• Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception.

  1999cited by this paper
• Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men

  1999cited by this paper
• Inhibitine Effects of Sino-implant Plus Testosterene Undecanoate （TU） on Spermatogenesis in Chinese Men

  1999cited by this paper
• Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.

  1999cited by this paper
• Inhibitine effects of sino-implant plus testosterone undecanoate (TU) on spermatogenesis in Chinese men.

  1999cited by this paper
• A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.

  1998cited by this paper
• Low dose of cyproterone acetate and testosterone enanthate for contraception in men.

  1998cited by this paper
• Contraceptive efficacy of testosterone‐induced azoospermia and oligozoospermia in normal men

  1996cited by this paper
• Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.

  1996cited by this paper
• A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.

  1996cited by this paper
• Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.

  1996influential reference
• Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.

  1996cited by this paper
• Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.

  1995cited by this paper
• London Perspective: The NHS gets out its begging bowl

  1990cited by this paper
• Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility.

  1990cited by this paper
• Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.

  1990cited by this paper
• Is high dosage testosterone an effective male contraceptive agent?

  1988cited by this paper
• Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants.

  1988cited by this paper
• Male contraception: clinical trials.

  1982cited by this paper
• Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control.

  1980cited by this paper
• Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.

  1980cited by this paper
• Hormonal Contraception for Men

  1978cited by this paper

• Progestins - a review of clinical application in gynecology

  2025cites this paper
• Male Hormonal Contraception—Current Stage of Knowledge

  2025influential citation
• Male Fertility as a Proxy for Health

  2024cites this paper
• To compare the clinical efficacy and side effects of implant (Jadelle) and IUCD (Copper T)

  2023influential citation
• Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines

  2023cites this paper
• Male Contraception Development: Monitoring Effective Spermatogenesis Suppression Utilizing a User-Controlled Sperm Concentration Test Compared with Standard Semen Analysis.

  2022cites this paper
• Male Contraception: Hormonal Methods

  2021cites this paper
• Acceptability of Male Hormonal Contraception

  2021cites this paper
• Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system

  2020cites this paper
• New frontiers in fertility preservation: a hypothesis on fertility optimization in men with hypergonadotrophic hypogonadism

  2020cites this paper
• New insights to guide patient care: the bidirectional relationship between male infertility and male health.

  2020cites this paper
• Reversible male contraceptives: Current progress

  2020cites this paper
• Testosterone replacement therapy and cardiovascular risk

  2019cites this paper
• Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11&bgr;-Methyl-19-Nortestosterone-17&bgr;-Dodecylcarbonate in Men

  2018cites this paper
• Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials.

  2018cites this paper
• Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility

  2018cites this paper
• Would male hormonal contraceptives affect cardiovascular risk?

  2018cites this paper
• Male hormonal contraception: hope and promise.

  2017cites this paper
• Hormonal, chemical and thermal inhibition of spermatogenesis: contribution of French teams to international data with the aim of developing male contraception in France

  2017influential citation
• [Male hormonal contraception: past, present, future].

  2017cites this paper
• Exogenous Androgens and Male Reproduction.

  2017cites this paper
• MALE CONTRACEPTION

  2017cites this paper
• Medical and Lifestyle Approaches to Improving Semen Quality

  2017cites this paper
• Opportunities for Enabling Puberty

  2017cites this paper
• Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.

  2016cites this paper
• Male Hormonal Contraception: Where Are We Now?

  2016cites this paper
• The current state of male hormonal contraception.

  2016cites this paper
• Induction of rat germ cell apoptosis by testosterone undecanoate and depot medroxyprogesterone acetate and correlation of apoptotic cells with sperm concentration.

  2016cites this paper
• Male contraception: a clinically-oriented review

  2015cites this paper
• Adverse effects of common medications on male fertility

  2015cites this paper
• Toward a Biology of Collectivism : Reducing the East West Divide to Its Physical and Physiological Substrates

  2015cites this paper
• Reproductive Endocrinology and Contraception in the Male

  2015cites this paper
• Toward a Biology of Collectivism

  2015cites this paper
• Pregnancy rates with intrauterine insemination: comparing 1999 and 2010 World Health Organization semen analysis norms.

  2015cites this paper
• Advances in male hormonal contraception

  2014cites this paper
• Male contraception.

  2014cites this paper
• Control de los nacimientos. esterilidad. infertilidad. disgenesiaAnticoncepción masculina

  2014cites this paper
• Contraception masculine

  2014cites this paper
• Medications With Male Reproductive Side Effects

  2014cites this paper
• Pharmaceutical Approaches and Advancements in Male Contraception

  2013cites this paper
• Testosterone and Its Analogs as a Male Contraceptive

  2013cites this paper
• Extended intervention time and evaluation of sperm suppression by dienogest plus testosterone undecanoate in male rat.

  2012cites this paper
• The insults of illicit drug use on male fertility.

  2012cites this paper
• Novel actions of progesterone: what we know today and what will be the scenario in the future?

  2012cites this paper
• A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

  2012cites this paper
• Steroid hormones for contraception in men.

  2012cites this paper
• Klinefelter syndrome: an argument for early aggressive hormonal and fertility management.

  2012cites this paper
• Male hormonal contraception: Potential risks and benefits

  2011influential citation
• Spermatogenetic inhibition in men taking a combination of oral medroxyprogesterone acetate and percutaneous testosterone as a male contraceptive method.

  2011cites this paper
• Male hormonal contraception.

  2010cites this paper
• Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function.

  2010cites this paper
• Hormonal approaches to male contraception

  2010cites this paper
• World Health Organization reference values for human semen characteristics.

  2010cites this paper
• Clinical trials in male hormonal contraception.

  2010cites this paper
• Body fat content and testosterone pharmacokinetics determine gonadotropin suppression after intramuscular injections of testosterone preparations in normal men.

  2009cites this paper
• Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.

  2009cites this paper
• Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.

  2009cites this paper
• Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study.

  2009cites this paper
• Advances in male contraception.

  2008cites this paper
• Hormonal Male Contraception: An Integrated Analysis Determinants of the Rate and Extent of Spermatogenic Suppression during

  2008cites this paper
• Male hormonal contraception: a double-blind, placebo-controlled study.

  2008cites this paper
• Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.

  2008cites this paper
• Luteinizing hormone-dependent Cushing's syndrome in a pet ferret (Mustela putorius furo).

  2008cites this paper
• Effectiveness of Highly Active Antiretroviral Therapy in HIV-Positive Children: Evaluation at 12 Months in a Routine Program in Cambodia

  2007cites this paper
• transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.

  2007cites this paper
• [Non-deferential male contraception: review of the literature].

  2007cites this paper
• Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.

  2007cites this paper
• Contraceptive developments for men.

  2007cites this paper
• Clinical Evaluation of Leydig Cell Function

  2007cites this paper
• Contraceptions masculines non dfrentielles : revue de la littrature

  2007cites this paper
• The quest for better contraception: future methods.

  2007cites this paper
• Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.

  2006cites this paper
• Male contraception: A realistic option?

  2006cites this paper
• Transient testicular warming enhances the suppressive effect of testosterone on spermatogenesis in adult cynomolgus monkeys (Macaca fascicularis).

  2006cites this paper
• The many faces of progesterone: a role in adult and developing male brain.

  2006cites this paper
• Drug Insight: recent advances in male hormonal contraception

  2006cites this paper
• Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis.

  2006cites this paper
• Advances in male hormonal contraception

  2006cites this paper
• Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.

  2006cites this paper
• Male Hormonal Contraceptives

  2006cites this paper
• Hormonal approaches to male contraception: approaching reality.

  2006cites this paper
• Male hormonal contraception: concept proven, product in sight?

  2006influential citation
• Androgens and male contraception

  2006cites this paper
• Advances in male hormone substitution therapy

  2005cites this paper
• Discovery and therapeutic promise of selective androgen receptor modulators.

  2005cites this paper
• Male hormonal contraceptives: a potentially patentable and profitable product

  2005cites this paper
• Male hormonal contraceptives: current status and future prospects.

  2005cites this paper
• Delivery options for contraceptives.

  2005cites this paper
• Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.

  2005cites this paper
• Original research article Steroid hormones for contraception in men: systematic review of randomized controlled trials

  2005cites this paper
• Steroid hormones for contraception in men: systematic review of randomized controlled trials.

  2005influential citation
• Decrease in serum dehydroepiandrosterone level after fenofibrate treatment in males with hyperlipidemia.

  2005cites this paper
• Update on male hormonal contraceptive agents

  2004cites this paper
• Male hormonal contraception

  2004cites this paper
• La contraception masculine

  2004cites this paper
• Progress towards hormonal male contraception.

  2004cites this paper
• Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.

  2004cites this paper
• Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.

  2004cites this paper
• Male hormonal contraception.

  2004cites this paper
• Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.

  2003cites this paper